Please Wait.....
Report
Cancer Immunotherapy - A Global Market Overview
Market Report I 2024-11-05 I 256 Pages I Industry Experts
Cancer Immunotherapy Market Trends and Outlook
Cancer immunotherapy, called immuno-oncotherapy, harnesses the body's immune system to identify and eliminate cancer cells. In contrast to traditional therapies like chemotherapy and radiation, which directly target cancer cells, immunotherapy enhances the immune response by utilizing tumor antigens that activate immune recognition. Monoclonal antibodies identify and tag cancer cells for elimination, while immune checkpoint inhibitors enhance the immune system's attack on tumors. Additionally, oncolytic viral therapies and cancer vaccines aim to destroy cancer cells or train the immune system to detect and attack cancer antigens more effectively. The effectiveness of these therapies varies across different cancer types, making them a significant focus in oncology research.
The global market for Cancer Immunotherapy is estimated at US$135.2 billion in 2024 and is anticipated to post a CAGR of 9.8% during the 2024-2030 analysis period and stand at a projected US$236.9 billion by 2030.
The global cancer immunotherapy market is primarily driven by the rising prevalence of cancer worldwide, leading to a growing demand for more effective treatment options. Oncolytic viral therapies and cancer vaccines use viruses to specifically target and destroy cancer cells, while Checkpoint inhibitors and CAR-T cell therapies are increasingly employed to treat lung cancer and melanoma. These therapies stimulate immune responses and are gaining attention due to their precise targeting and reduced side effects, further driving market demand. Advancements in biotechnology, including gene editing and bioinformatics, have enabled the development of personalized and efficient therapies. Additionally, investments in research and development and a supportive regulatory environment have accelerated the introduction of innovative treatments.
Cancer Immunotherapy Regional Market Analysis
North America dominates the market and is expected to hold an estimated share of 43.7% in 2024, primarily due to the increasing demand for advanced treatment options, a strong presence of major market players, and substantial investments in research and development. The United States leads this growth with favorable reimbursement policies and advanced healthcare infrastructure, which facilitates the adoption of immunotherapies. On the other hand, the Asia Pacific region is poised to be the fastest-growing market, with a projected CAGR of 11.3% during the forecast period 2024-2030. This growth is driven by a rising population of cancer patients, increased healthcare expenditures, and a growing awareness of innovative therapies in countries such as China and India. Government efforts to enhance healthcare infrastructure and a growing private sector are further driving this expansion, addressing the critical need for effective cancer treatments in both regions.
Cancer Immunotherapy Market Analysis by Product
The Monoclonal Antibodies segment dominates the cancer immunotherapy market, holding a projected share of 55.9% in 2024. This dominance is driven by growing R&D investments in bispecific, conjugated, and naked antigen-binding antibodies, which have created new growth opportunities in oncology therapeutics. These antibodies enhance adaptive immunity and specifically target cancer antigens, resulting in improved therapeutic outcomes with reduced side effects. In contrast, the Oncolytic Viral Therapies and Cancer Vaccines segment is expected to be the fastest-growing, with a projected CAGR of 11.8% during the analysis period 2024-2030, despite facing challenges like immunogenicity and immunosuppression in tumor environments.
Cancer Immunotherapy Market Analysis by Application
The lung cancer application is anticipated to maintain its dominant position by holding the largest market share of 13.8% in 2024. This growth is driven by the increasing prevalence of lung cancer, primarily due to increased smoking and the popularity of harmful products such as e-cigarettes. As the leading cause of cancer-related deaths globally, lung cancer requires immunotherapy treatments to manage the advanced stages of the disease. Meanwhile, the breast cancer application is expected to be the fastest-growing segment, with a projected CAGR of 13.5% during the forecast period 2024-2030, driven by the high prevalence of breast cancer, ongoing research and development efforts, and increased investments by leading players to develop novel therapeutics. The rising number of breast cancer cases among women globally further fuels this segment's expansion.
Cancer Immunotherapy Market Analysis by End-User
The Hospitals & Clinics segment is the largest end-user market, with an estimated share of 49.8% in 2024, primarily driven by the rising incidence of cancer, increased treatment rates, improved awareness, and the availability of immunotherapy treatments across numerous hospitals. The segment's significance is further strengthened by the growing number of hospital admissions for cancer treatment and the increased adoption of advanced therapies. Conversely, the Cancer Research Centers segment is anticipated to record the fastest growth with a CAGR of 10.9% during the analysis period from 2024 to 2030. This growth is driven by increasing investments in cancer research from corporate and government organizations, along with advancements in immunotherapy treatments.
Cancer Immunotherapy Market Report Scope
This global report on Cancer Immunotherapy analyzes the market based on product, application, and end-users. In addition to providing profiles of major companies operating in this space, the latest corporate and industrial developments have been covered to offer a clear panorama of how and where the market is progressing.
Key Metrics
Historical Period: 2021-2023
Base Year: 2023
Forecast Period: 2024-2030
Units: Value market in US$
Companies Mentioned: 10+
Cancer Immunotherapy Market by Geographic Region
- North America (The United States, Canada, and Mexico)
- Europe (Germany, France, United Kingdom, Italy, Spain, and Rest of Europe)
- Asia-Pacific (Japan, China, India, South Korea, and Rest of Asia-Pacific)
- South America (Brazil, Argentina, and Rest of South America)
- Rest of World
Cancer Immunotherapy Market by Product
- Monoclonal Antibodies
- Oncolytic Viral Therapies & Cancer Vaccines
- Checkpoint Inhibitors & Immunomodulators
Cancer Immunotherapy Market by Application
- Lung Cancer
- Breast Cancer
- Colorectal Cancer
- Skin Cancer
- Prostate Cancer
- Stomach Cancer
- Head & Neck Cancer
- Others (Including Blood, Ovarian, Cervical, Kidney, Liver, Bladder, Pancreatic, and other cancers)
Cancer Immunotherapy Market by End-User
- Hospitals & Clinics
- Cancer Research Centers
- Other End-Users (Including Ambulatory Surgical Centers (ASCs), and Homecare settings)
PART A: GLOBAL MARKET PERSPECTIVE
1. INTRODUCTION
- Product Outline
- Cancer Immunotherapy Defined
- Cancer Immunotherapy Products
o Monoclonal Antibodies
o Oncolytic Viral Therapies & Cancer Vaccines
o Checkpoint Inhibitors & Immunomodulators
- Cancer Immunotherapy Applications
o Lung Cancer
o Breast Cancer
o Colorectal Cancer
o Skin Cancer
o Prostate Cancer
o Stomach Cancer
o Head & Neck Cancer
o Others (Including Blood, Ovarian, Cervical, Kidney, Liver, Bladder, Pancreatic, and other cancers)
- Cancer Immunotherapy End-Users
o Hospitals & Clinics
o Cancer Research Centers
o Other End-Users (Including Ambulatory Surgical Centers (ASCs), and Homecare settings)
2. Key Market Trends
3. Key Global Players
- Amgen Inc.
- AstraZeneca plc
- Bayer AG
- Bristol-Myers Squibb Company
- Eli Lilly and Company
- F. Hoffmann-La Roche AG
- GSK Plc
- Immunocore Holdings Plc
- Johnson & Johnson Innovative Medicine
- Merck & Co., Inc.
- Novartis AG
- Pfizer Inc.
4. Key Business & Product Trends
5. Global Market Overview
- Global Cancer Immunotherapy Market Overview by Product
o Cancer Immunotherapy Product Market Overview by Global Region
- Monoclonal Antibodies
- Oncolytic Viral Therapies & Cancer Vaccines
- Checkpoint Inhibitors & Immunomodulators
- Global Cancer Immunotherapy Market Overview by Application
o Cancer Immunotherapy Application Market Overview by Global Region
- Lung Cancer
- Breast Cancer
- Colorectal Cancer
- Skin Cancer
- Prostate Cancer
- Stomach Cancer
- Head & Neck Cancer
- Others
- Global Cancer Immunotherapy Market Overview by End-User
o Cancer Immunotherapy End-User Market Overview by Global Region
- Hospitals & Clinics
- Cancer Research Centers
- Other End-Users
PART B: REGIONAL MARKET PERSPECTIVE
Global Cancer Immunotherapy Market Overview by Geographic Region
REGIONAL MARKET OVERVIEW
6. North America
- North American Cancer Immunotherapy Market Overview by Geographic Region
- North American Cancer Immunotherapy Market Overview by Product
- North American Cancer Immunotherapy Market Overview by Application
- North American Cancer Immunotherapy Market Overview by End-User
- Country-wise Analysis of North American Cancer Immunotherapy Market
o The United States
- United States Cancer Immunotherapy Market Overview by Product
- United States Cancer Immunotherapy Market Overview by Application
- United States Cancer Immunotherapy Market Overview by End-User
o Canada
- Canadian Cancer Immunotherapy Market Overview by Product
- Canadian Cancer Immunotherapy Market Overview by Application
- Canadian Cancer Immunotherapy Market Overview by End-User
o Mexico
- Mexican Cancer Immunotherapy Market Overview by Product
- Mexican Cancer Immunotherapy Market Overview by Application
- Mexican Cancer Immunotherapy Market Overview by End-User
7. Europe
- European Cancer Immunotherapy Market Overview by Geographic Region
- European Cancer Immunotherapy Market Overview by Product
- European Cancer Immunotherapy Market Overview by Application
- European Cancer Immunotherapy Market Overview by End-User
- Country-wise Analysis of European Cancer Immunotherapy Market
o Germany
- German Cancer Immunotherapy Market Overview by Product
- German Cancer Immunotherapy Market Overview by Application
- German Cancer Immunotherapy Market Overview by End-User
o France
- French Cancer Immunotherapy Market Overview by Product
- French Cancer Immunotherapy Market Overview by Application
- French Cancer Immunotherapy Market Overview by End-User
o The United Kingdom
- United Kingdom Cancer Immunotherapy Market Overview by Product
- United Kingdom Cancer Immunotherapy Market Overview by Application
- United Kingdom Cancer Immunotherapy Market Overview by End-User
o Italy
- Italian Cancer Immunotherapy Market Overview by Product
- Italian Cancer Immunotherapy Market Overview by Application
- Italian Cancer Immunotherapy Market Overview by End-User
o Spain
- Spanish Cancer Immunotherapy Market Overview by Product
- Spanish Cancer Immunotherapy Market Overview by Application
- Spanish Cancer Immunotherapy Market Overview by End-User
o Rest of Europe
- Rest of Europe Cancer Immunotherapy Market Overview by Product
- Rest of Europe Cancer Immunotherapy Market Overview by Application
- Rest of Europe Cancer Immunotherapy Market Overview by End-User
8. Asia-Pacific
- Asia-Pacific Cancer Immunotherapy Market Overview by Geographic Region
- Asia-Pacific Cancer Immunotherapy Market Overview by Product
- Asia-Pacific Cancer Immunotherapy Market Overview by Application
- Asia-Pacific Cancer Immunotherapy Market Overview by End-User
- Country-wise Analysis of Asia-Pacific Cancer Immunotherapy Market
o Japan
- Japanese Cancer Immunotherapy Market Overview by Product
- Japanese Cancer Immunotherapy Market Overview by Application
- Japanese Cancer Immunotherapy Market Overview by End-User
o China
- Chinese Cancer Immunotherapy Market Overview by Product
- Chinese Cancer Immunotherapy Market Overview by Application
- Chinese Cancer Immunotherapy Market Overview by End-User
o India
- Indian Cancer Immunotherapy Market Overview by Product
- Indian Cancer Immunotherapy Market Overview by Application
- Indian Cancer Immunotherapy Market Overview by End-User
o South Korea
- South Korean Cancer Immunotherapy Market Overview by Product
- South Korean Cancer Immunotherapy Market Overview by Application
- South Korean Cancer Immunotherapy Market Overview by End-User
o Rest of Asia-Pacific
- Rest of Asia-Pacific Cancer Immunotherapy Market Overview by Product
- Rest of Asia-Pacific Cancer Immunotherapy Market Overview by Application
- Rest of Asia-Pacific Cancer Immunotherapy Market Overview by End-User
9. South America
- South American Cancer Immunotherapy Market Overview by Geographic Region
- South American Cancer Immunotherapy Market Overview by Product
- South American Cancer Immunotherapy Market Overview by Application
- South American Cancer Immunotherapy Market Overview by End-User
- Country-wise Analysis of Asia-Pacific Cancer Immunotherapy Market
o Brazil
- Brazilian Cancer Immunotherapy Market Overview by Product
- Brazilian Cancer Immunotherapy Market Overview by Application
- Brazilian Cancer Immunotherapy Market Overview by End-User
o Argentina
- Argentine Cancer Immunotherapy Market Overview by Product
- Argentine Cancer Immunotherapy Market Overview by Application
- Argentine Cancer Immunotherapy Market Overview by End-User
o Rest of South America
- Rest of South American Cancer Immunotherapy Market Overview by Product
- Rest of South American Cancer Immunotherapy Market Overview by Application
- Rest of South American Cancer Immunotherapy Market Overview by End-User
10. Rest of World
- Rest of World Cancer Immunotherapy Market Overview by Product
- Rest of World Cancer Immunotherapy Market Overview by Application
- Rest of World Cancer Immunotherapy Market Overview by End-User
PART C: GUIDE TO THE INDUSTRY
PART D: ANNEXURE
1. RESEARCH METHODOLOGY
2. FEEDBACK
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security